1. MARKETS
  2. SECTOR : COMMERCIAL SERVICES & SUPPLIES
  3. INDUSTRY : MISCELLANEOUS COMMERCIAL SERVICES
  4. LONGBOARD PHARMACEUTICALS INC

Longboard Pharmaceuticals Inc

XNAS: LBPH

Watchlist

Portfolio

Share


Insider Trading disclosures for Longboard Pharmaceuticals Inc

The latest disclosure was made by Phillip M. Schneider in Longboard Pharmaceuticals Inc where a trade of 25,461 Employee Stock Option (right to buy) done was reported to US exchanges on Dec. 2, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Phillip M. Schneider Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 25,461 0 - - Employee Stock Option (right to buy)
Phillip M. Schneider Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 22,500 0 - - Employee Stock Option (right to buy)
Phillip M. Schneider Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,500 0 - - Employee Stock Option (right to buy)
Phillip M. Schneider Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,367 0 - - Employee Stock Option (right to buy)
Randall E. Kaye Executive Vice President & CMO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 9,500 0 - - Restricted Stock Unit
Randall E. Kaye Executive Vice President & CMO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 175,946 0 - - Employee Stock Option (right to buy)
Randall E. Kaye Executive Vice President & CMO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 96,300 0 - - Employee Stock Option (right to buy)
Randall E. Kaye Executive Vice President & CMO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 107,560 0 - - Employee Stock Option (right to buy)
Randall E. Kaye Executive Vice President & CMO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 17,920 0 - - Restricted Stock Unit
Randall E. Kaye Executive Vice President & CMO 02 Dec 2024 30,554 0 - 60 1,833,240 Common Stock
Paul J. Sekhri Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 22,500 0 - - Employee Stock Option (right to buy)
Paul J. Sekhri Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,500 0 - - Employee Stock Option (right to buy)
Paul J. Sekhri Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,367 0 - - Employee Stock Option (right to buy)
Paul J. Sekhri Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 25,461 0 - - Employee Stock Option (right to buy)
Brandi L. Roberts Executive VP and CFO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 90,000 0 - - Employee Stock Option (right to buy)
Brandi L. Roberts Executive VP and CFO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 7,900 0 - - Restricted Stock Unit
Brandi L. Roberts Executive VP and CFO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 15,090 0 - - Restricted Stock Unit
Brandi L. Roberts Executive VP and CFO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 90,580 0 - - Employee Stock Option (right to buy)
Brandi L. Roberts Executive VP and CFO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 119,700 0 - - Employee Stock Option (right to buy)
Brandi L. Roberts Executive VP and CFO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 139,380 0 - - Employee Stock Option (right to buy)
Vincent E. Aurentz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,367 0 - - Employee Stock Option (right to buy)
Vincent E. Aurentz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 7,214 0 - - Employee Stock Option (right to buy)
Vincent E. Aurentz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,367 0 - - Employee Stock Option (right to buy)
Vincent E. Aurentz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,500 0 - - Employee Stock Option (right to buy)
Vincent E. Aurentz Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 22,500 0 - - Employee Stock Option (right to buy)
Kevin R. Lind Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 22,000 0 - - Restricted Stock Unit
Kevin R. Lind Director, President and CEO 02 Dec 2024 363,740 0 - 60 21,824,400 Common Stock
Kevin R. Lind Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 332,134 0 - - Employee Stock Option (right to buy)
Kevin R. Lind Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 325,850 0 - - Employee Stock Option (right to buy)
Kevin R. Lind Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 192,783 0 - - Employee Stock Option (right to buy)
Kevin R. Lind Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 255,377 0 - - Employee Stock Option (right to buy)
Casey C. Lynch Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 22,500 0 - - Employee Stock Option (right to buy)
Casey C. Lynch Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,367 0 - - Employee Stock Option (right to buy)
Casey C. Lynch Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 14,428 0 - - Employee Stock Option (right to buy)
Casey C. Lynch Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,367 0 - - Employee Stock Option (right to buy)
Casey C. Lynch Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,500 0 - - Employee Stock Option (right to buy)
Corinne Le Goff Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,367 0 - - Employee Stock Option (right to buy)
Corinne Le Goff Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 13,397 0 - - Employee Stock Option (right to buy)
Corinne Le Goff Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,367 0 - - Employee Stock Option (right to buy)
Corinne Le Goff Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 22,500 0 - - Employee Stock Option (right to buy)
Corinne Le Goff Director Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Dec 2024 12,500 0 - - Employee Stock Option (right to buy)
Randall E. Kaye CMO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Nov 2024 30,554 175,946 - - Stock Option (Right to Buy)
Randall E. Kaye CMO Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.00 per share. 19 Nov 2024 30,554 48,474 - 6 183,324 Common Stock
Kevin R. Lind Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Nov 2024 12,808 255,377 - - Stock Option (Right to Buy)
Kevin R. Lind Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. 13 Nov 2024 12,808 443,740 - 3.1 40,002 Common Stock
Kevin R. Lind Director, CEO Gift of securities by or to the insider at price $ 0.00 per share. 13 Nov 2024 80,000 363,740 - 0 Common Stock
Randall E. Kaye CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2024 9,500 9,500 - - Retention Restricted Stock Units
Brandi L. Roberts CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2024 7,900 7,900 - - Retention Restricted Stock Units
Kevin R. Lind Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2024 22,000 22,000 - - Retention Restricted Stock Units
Randall E. Kaye CMO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.35 per share. 15 Oct 2024 16,667 34,587 - 4.3 72,501 Common Stock
Randall E. Kaye CMO Sale of securities on an exchange or to another person at price $ 59.03 per share. 15 Oct 2024 16,667 17,920 - 59.0 983,936 Common Stock
Randall E. Kaye CMO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 16,667 96,300 - - Stock Option (Right to Buy)
Randall E. Kaye CMO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.35 per share. 16 Sep 2024 16,666 34,586 - 4.3 72,497 Common Stock
Randall E. Kaye CMO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Sep 2024 16,666 112,967 - - Stock Option (Right to Buy)
Randall E. Kaye CMO Sale of securities on an exchange or to another person at price $ 34.04 per share. 16 Sep 2024 1,900 17,920 - 34.0 64,668 Common Stock
Randall E. Kaye CMO Sale of securities on an exchange or to another person at price $ 33.12 per share. 16 Sep 2024 1,200 19,820 - 33.1 39,750 Common Stock
Randall E. Kaye CMO Sale of securities on an exchange or to another person at price $ 31.81 per share. 16 Sep 2024 4,200 21,020 - 31.8 133,622 Common Stock
Randall E. Kaye CMO Sale of securities on an exchange or to another person at price $ 30.89 per share. 16 Sep 2024 9,366 25,220 - 30.9 289,278 Common Stock
Kevin R. Lind Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2024 2,217 192,783 - - Stock Option (Right to Buy)
Kevin R. Lind Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. 12 Aug 2024 80,265 428,715 - 3.1 250,684 Common Stock
Kevin R. Lind Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. 12 Aug 2024 2,217 430,932 - 4.2 9,311 Common Stock
Kevin R. Lind Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2024 80,265 268,185 - - Stock Option (Right to Buy)
Phillip M. Schneider Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 22,500 22,500 - - Stock Option (Right to Buy)
Paul J. Sekhri Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 22,500 22,500 - - Stock Option (Right to Buy)
Vincent E. Aurentz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 22,500 22,500 - - Stock Option (Right to Buy)
Casey C. Lynch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 22,500 22,500 - - Stock Option (Right to Buy)
Corinne Le Goff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 22,500 22,500 - - Stock Option (Right to Buy)
Roberts Brandi L. CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 15,090 15,090 - 0 Common Stock
Kaye E. Randall CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 107,560 107,560 - - Stock Option (Right to Buy)
E. Randall Kaye CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 17,920 17,920 - 0 Common Stock
R. Lind Kevin Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 332,134 332,134 - - Stock Option (Right to Buy)
L. Roberts Brandi CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2024 90,580 90,580 - - Stock Option (Right to Buy)
Randall E. Kaye CMO Purchase of securities on an exchange or from another person at price $ 24.82 per share. 23 Jan 2024 100 100 - 24.8 2,482 Common Stock
Randall E. Kaye CMO Sale of securities on an exchange or to another person at price $ 20.87 per share. 23 Jan 2024 100 0 - 20.9 2,087 Common Stock
Randall E. Kaye CMO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.35 per share. 23 Jan 2024 16,667 34,587 - 4.3 72,501 Common Stock
Randall E. Kaye CMO Sale of securities on an exchange or to another person at price $ 34.55 per share. 23 Jan 2024 10,476 24,111 - 34.6 361,948 Common Stock
Randall E. Kaye CMO Sale of securities on an exchange or to another person at price $ 35.03 per share. 23 Jan 2024 6,191 17,920 - 35.0 216,856 Common Stock
Randall E. Kaye CMO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jan 2024 16,667 129,633 - - Stock Option (Right to Buy)
Phillip M. Schneider Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 12,500 12,500 - - Stock Option (Right to Buy)
Paul J. Sekhri Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 12,500 12,500 - - Stock Option (Right to Buy)
Vincent Aurentz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 12,500 12,500 - - Stock Option (Right to Buy)
Casey C. Lynch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 12,500 12,500 - - Stock Option (Right to Buy)
Corinne Le Goff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 12,500 12,500 - - Stock Option (Right to Buy)
Randall E. Kaye CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 146,300 146,300 - - Stock Option (Right to Buy)
Brandi L. Roberts CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 119,700 119,700 - - Stock Option (Right to Buy)
Kevin R. Lind Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2023 325,850 325,850 - - Stock Option (Right to Buy)
Phillip M. Schneider Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 12,367 12,367 - - Stock Option (Right to Buy)
Paul J. Sekhri Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 12,367 12,367 - - Stock Option (Right to Buy)
Vincent Aurentz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 12,367 12,367 - - Stock Option (Right to Buy)
Casey C. Lynch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 12,367 12,367 - - Stock Option (Right to Buy)
Corinne Le Goff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 12,367 12,367 - - Stock Option (Right to Buy)
Jane Tiller Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 12,367 12,367 - - Stock Option (Right to Buy)
Randall E. Kaye CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2022 206,500 206,500 - - Stock Option (Right to Buy)
Philip Perera CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2022 95,000 95,000 - - Stock Option (Right to Buy)
Jane Tiller Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2021 5,152 5,152 - - Stock Option (Right to Buy)
Jane Tiller Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2021 12,367 12,367 - - Stock Option (Right to Buy)
Vincent Aurentz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Sep 2021 7,214 7,214 - - Stock Option (Right to Buy)
Vincent Aurentz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Sep 2021 12,367 12,367 - - Stock Option (Right to Buy)
Casey C. Lynch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 14,428 14,428 - - Stock Option (Right to Buy)
Casey C. Lynch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 12,367 12,367 - - Stock Option (Right to Buy)
Corinne Le Goff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 13,397 13,397 - - Stock Option (Right to Buy)
Corinne Le Goff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 12,367 12,367 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters